Review

Title Average Ratingsort ascending
Intermittent androgen deprivation therapy: redefining the standard of care? 100.00%
The need for ibogaine in drug and alcohol addiction treatment. 100.00%
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. 95.00%
Low-dose naltrexone for disease prevention and quality of life. 95.00%
Albumin Concentration Controls Cancer 90.00%
Hyperthermia adds to chemotherapy. 90.00%
Vitamin D for cancer prevention: global perspective. 90.00%
Improving conventional or low dose metronomic chemotherapy with targeted antiangiogenic drugs. 90.00%
Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized ........ 90.00%
The present state of antineoplaston research (1) 90.00%
Why are tumour blood vessels abnormal and why is it important to know? 90.00%
Valproic acid: an old drug newly discovered as inhibitor of histone deacetylases. 90.00%
Metronomic chemotherapy: changing the paradigm that more is better. 90.00%
Pomegranate juice: a heart-healthy fruit juice. 90.00%
The Biofield Hypothesis: Its Biophysical Basis and Role in Medicine 90.00%
Obesity, hyperinsulinemia and breast cancer: novel targets and a novel role for metformin. 90.00%
Is it time to test metformin in breast cancer clinical trials? 90.00%
Medicinal plants and cancer chemoprevention. 90.00%
Randomized Trials of Selenium, Vitamin E, or Vitamin C for Prostate Cancer Prevention 90.00%
Immunomodulatory effects of opioids. 90.00%
Immune-modifying and antimicrobial effects of Eucalyptus oil and simple inhalation devices 90.00%
Current impediments to acceptance of the ultraviolet-B-vitamin D-cancer hypothesis. 90.00%
The use of mushroom glucans and proteoglycans in cancer treatment. 90.00%
Systems biology: a therapeutic target for tumor therapy. 86.67%
The anti-angiogenic basis of metronomic chemotherapy. 85.00%
Individual Patient Data Meta-analysis of Survival and Psychosomatic Self-regulation from Published Prospective Controlled Cohort 80.00%
Modified citrus pectin anti-metastatic properties: one bullet, multiple targets. 80.00%
How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. 80.00%
Opiates and infection. 80.00%
Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin--from bench to bedside. 80.00%
Variations of the piriformis and sciatic nerve with clinical consequence: a review 80.00%
Lipidomics: the function of vital lipids in embryogenesis preventing autism spectrum disorders, treating sterile inflammatory di 80.00%
Regional hyperthermia in high-risk soft tissue sarcomas. 80.00%
Clinical applications of magnetic nanoparticles for hyperthermia. 80.00%
Presence of nanobacteria in psammoma bodies of ovarian cancer: evidence for pathogenetic role in intratumoral biomineralization. 80.00%
Boswellic acids: biological actions and molecular targets. 80.00%
Antitumor properties and modulation of antioxidant enzymes' activity by Aloe vera leaf active principles isolated via supercriti 80.00%
Enhanced radiation sensitivity and radiation recall dermatitis (RRD) after hypericin therapy – case report and review of literat 80.00%
Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecula 80.00%
Newcastle disease virus as an oncolytic agent. 80.00%
The emerging low-dose therapy for advanced cancers. 80.00%
Hyperthermia and Immunity. A Brief Overview 70.00%
Clinical results of N-acetylcysteine after major hepatic surgery: a review. 70.00%
Antiangiogenic (metronomic) chemotherapy for brain tumors: current and future perspectives. 70.00%
Circulating tumor cells in gastrointestinal malignancies: current techniques and clinical implications. 70.00%
Anti-cancer drugs that target metabolism, is dichloroacetate the new paradigm? 70.00%
Hypoxia in cancer: significance and impact on clinical outcome. 70.00%
Angiogenesis and cancer: A cross-talk between basic science and clinical trials (the "do ut des" paradigm). 70.00%
Novel dammarane-type sapogenins from Panax ginseng berry and their biological activities. 70.00%
Radiosurgery for spinal malignant tumors. 70.00%
Energy metabolism, proteotoxic stress and age-related dysfunction - protection by carnosine. 70.00%
Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies. 70.00%
Garlic, or Allium sativum: a review of its potential use as an anti-cancer agent. 70.00%
Effects of opioids on the immune system. 70.00%
Boswellia serrata: An Overall Assessment of In Vitro, Preclinical, Pharmacokinetic and Clinical Data. 70.00%
Todoxin against AIDS/HIV 66.67%
Vitamin D and prostate cancer risk: a review of the epidemiological literature. 60.00%
Review on molecular and therapeutic potential of thymoquinone in cancer. 60.00%
The oil-dispersion bath in Anthroposophic Medicine - an integrative review. 60.00%
Is there a role for herbal medicine in the treatment of pancreatic cancer?. Highlights from the "44th ASCO Annual Meeting". 60.00%
Focal therapy for prostate cancer: revolution or evolution? 60.00%
N-Acetylcysteine: Multiple Clinical Applications 60.00%
Programmed drug delivery: nanosystems for tumor targeting. 60.00%
Fruit and berries--interactions with drugs 60.00%
Is there a standard of care for the management of advanced pancreatic cancer?. Highlights from the Gastrointestinal Cancers Symp 60.00%
Systematic review of the treatment of cancer-associated anorexia and weight loss. 60.00%
Anti-angiogenic therapies for metastatic colorectal cancer. 60.00%
Fatalities Temporally Associated with the Ingestion of Ibogaine. 60.00%
Antiangiogenic drugs currently used for colorectal cancer: what other pathways can we target to prolong responses? 60.00%
Unconventional anticancer agents: a systematic review of clinical trials. 60.00%
Review. Current role and future perspectives of hyperthermia for prostate cancer treatment. 60.00%
Clinical management of adrenocortical carcinoma 60.00%
Systematic review: Cyclo-oxygenase-2 in human oesophageal adenocarcinogenesis. 50.00%
Role of everolimus in the treatment of renal cell carcinoma. 50.00%
Chemoradiotherapy in malignant glioma: standard of care and future directions. 50.00%
Toxic effects and their management: daily clinical challenges in the treatment of colorectal cancer. 50.00%
Die Rolle von Boswellia-Säuren in der Therapie maligner Gliome: Methodische Mängel 50.00%
Lessons learned in the development of targeted therapy for malignant gliomas 50.00%
WITHDRAWN: Ovarian ablation for early breast cancer. 50.00%
Novel anti-angiogenic therapies for malignant gliomas. 50.00%
Therapy innovations: tyrosine kinase inhibitors for the treatment of pancreatic neuroendocrine tumors. 50.00%
Tumoral angiogenesis: review of the literature. 50.00%
Long term outcomes following surgical resection of myxopapillary ependymomas. 40.00%
Ependymoma. 40.00%
Pancreatic cancer stem cells - insights and perspectives. 40.00%
Management of the patient and family with neurofibromatosis 2: a consensus conference statement. 30.00%
Mistletoe as a treatment for cancer. Has no proved benefit, and can cause harm 20.00%
Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer........ 0.00%
Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate. 0.00%
The value of proteasome inhibition in cancer. Can the old drug, disulfiram, have a bright new future as a novel proteasome inhib 0.00%